Bloomberg Businessweek, one of the top business publications in the US, this week took a look at the question of the Lyme disease vaccine. Currently dubbed VLA15, the vaccine is being developed by Pfizer, Inc, in partnership with French drug maker Valneva SE. In the final phase... Read More »